Trial Profile
Utility of resistance index (RI) measured with renal doppler ultrasonography to elucidate induction therapy of Tolvaptan
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2017
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites; Liver cirrhosis
- Focus Therapeutic Use
- 22 Jun 2017 New trial record